COMPANY

OpenCell Technologies

HQ: St. Louis, MO source · opencelltech.com ↗ · Midwest

Location: St. Louis, MO · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $287K (SBIR Phase I 1R43CA310210-01A1, new, notice Sep 15, 2026). NIH RePORTER 1R43CA310210-01A1 (Sep 15, 2026)
Evidence (1 event)
- Sep 15, 2026 · NIH RePORTER 1R43CA310210-01A1
  Organization: OPENCELL TECHNOLOGIES, INC.; City/State: SAINT LOUIS, MO; Project number: 1R43CA310210-01A1; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-09-15; FY total cost (award amount): 287125; Administering IC: National Cancer Institute; Project title: Enhancing NK Cell Engineering Through Optimized SoftPoration(TM) for Cell-Based Therapeutics; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 15, 2026 Grant Government grant — SBIR: $287,125 (annual award, as published), announced Sep 15, 2026. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Sep 15, 2026 Government grant — SBIR: $287,125 (annual award, as published), announced Sep 15, 2026. Agency: NIH/NCI. Source: government award database. source ↗